The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines. Budesonide suppository (Budenofalk®) has been accepted for the short-term treatment of mild to moderate acute ulcerative colitis limited to the rectum... https://www.prescriber.org.uk/?p=1870
12.11.2025 08:04 — 👍 0 🔁 0 💬 0 📌 0
A Medicines Supply Notification has been distributed by NHS England and the Department of Health and Social Care advising the exenatide (Bydureon®) 2mg/0.85ml prolonged-release suspension for injection pre-filled pen has been discontinued. The notification... https://www.prescriber.org.uk/?p=1869
06.11.2025 08:38 — 👍 0 🔁 0 💬 0 📌 0
During October 2025 Clinical Knowledge Summaries were published or updated in the following areas. Anticoagulation - oral Contraception - progestogen-only methods Diabetes - type 1 Earwax HIV infection and AIDS Mental health in students Osgood-Schlatter... https://www.prescriber.org.uk/?p=1868
04.11.2025 08:09 — 👍 0 🔁 0 💬 0 📌 0
The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Drug Safety Update article for October 2025. This update is a call to action to improve patient safety linked to #MedSafetyWeek. This is an annual campaign taking place from 3 to... https://www.prescriber.org.uk/?p=1867
24.10.2025 08:21 — 👍 1 🔁 0 💬 0 📌 0
The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of October 2025. This month there is one technology appraisal and one guideline that impact upon primary care. The Mirabegron for treating... https://www.prescriber.org.uk/?p=1866
20.10.2025 08:49 — 👍 0 🔁 0 💬 0 📌 0
The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines. Linzagolix (Yselty®) has been accepted for use in adult women of reproductive age for symptomatic treatment of endometriosis in women with a history of... https://www.prescriber.org.uk/?p=1865
14.10.2025 06:46 — 👍 0 🔁 0 💬 0 📌 0
The Department of Health and Social Care has recently announced a change to the prescribing restrictions for antiviral medicines for influenza. The requirement that an notification be issued by the Chief Medical Officer has been removed. Prescribing of... https://www.prescriber.org.uk/?p=1864
09.10.2025 07:08 — 👍 0 🔁 0 💬 0 📌 0
During September 2025 Clinical Knowledge Summaries were published or updated in the following areas. Acute childhood limp Addison's disease Baker's cyst Constipation in children Glaucoma Multiple myeloma Tiredness/fatigue in adults All of the topics have... https://www.prescriber.org.uk/?p=1863
06.10.2025 06:44 — 👍 0 🔁 0 💬 0 📌 0
The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of September 2025. This month there are two technology appraisals, five guidelines and two health technology evaluations that impact upon... https://www.prescriber.org.uk/?p=1862
26.09.2025 06:40 — 👍 0 🔁 0 💬 0 📌 0
The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Drug Safety Update article for September 2025. This update reminds and reassures patients and clinicians that there is no evidence that taking paracetamol during pregnancy causes... https://www.prescriber.org.uk/?p=1861
23.09.2025 18:45 — 👍 0 🔁 0 💬 0 📌 0
The manufacturer of Levemir® (insulin detemir) has announced a decision to discontinue this product in both the pre-filled pens (FlexPen) and cartridges with supplies expected to exhausted by the end of 2026. The Specialist Pharmacy Service offers more... https://www.prescriber.org.uk/?p=1860
08.09.2025 07:02 — 👍 0 🔁 0 💬 0 📌 0
During August 2025 Clinical Knowledge Summaries were published or updated in the following areas. Bone and soft tissue sarcoma - recognition and referral Brain and central nervous system cancers - recognition and referral Breast cancer - recognition and... https://www.prescriber.org.uk/?p=1859
03.09.2025 06:56 — 👍 0 🔁 0 💬 0 📌 0
The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of August 2025. This month there is one health technology evaluation that impacts upon primary care. The Compression products for treating... https://www.prescriber.org.uk/?p=1858
28.08.2025 07:32 — 👍 0 🔁 0 💬 0 📌 0
During July 2025 Clinical Knowledge Summaries were published or updated in the following areas. Coeliac disease Diabetes - type 2 Falls - assessment Immunizations - childhood Immunizations - travel Insulin therapy in type 2 diabetes Jaundice in adults... https://www.prescriber.org.uk/?p=1857
05.08.2025 07:10 — 👍 0 🔁 0 💬 0 📌 0
The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of July 2025. This month there are two technology appraisals and one health technology evaluation that impact upon primary care. The... https://www.prescriber.org.uk/?p=1856
31.07.2025 07:12 — 👍 0 🔁 0 💬 0 📌 0
The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Drug Safety Update article for July 2025. This update warns clinicians about a small increase in the risk of Guillain-Barré syndrome following vaccination with respiratory... https://www.prescriber.org.uk/?p=1855
18.07.2025 06:45 — 👍 0 🔁 0 💬 0 📌 0
The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines. Fezolinetant (Veoza®) has been rejected for use in the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause. The submitting... https://www.prescriber.org.uk/?p=1854
09.07.2025 06:35 — 👍 0 🔁 0 💬 0 📌 0
During June 2025 Clinical Knowledge Summaries were published or updated in the following areas. Corticosteroids - oral Hand, foot, and mouth disease Hepatitis C Immunizations - seasonal influenza Jaundice in the newborn Myalgic encephalomyelitis/chronic... https://www.prescriber.org.uk/?p=1853
02.07.2025 07:07 — 👍 0 🔁 0 💬 0 📌 0
The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of June 2025. This month there is one guideline, one technology appraisal and one health technology evaluation that impact upon primary care.... https://www.prescriber.org.uk/?p=1852
23.06.2025 06:53 — 👍 0 🔁 0 💬 0 📌 0
The Medicines and Healthcare products Regulatory Agency (MHRA) has published two Drug Safety Update articles for June 2025. Earlier this month updated safety and educational materials were made available to support the implementation of the regulatory... https://www.prescriber.org.uk/?p=1851
20.06.2025 07:06 — 👍 0 🔁 0 💬 0 📌 0
The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines. Bempedoic acid (Nilemdo®) has been rejected for use in adults with established or at high risk for atherosclerotic cardiovascular disease to reduce... https://www.prescriber.org.uk/?p=1850
10.06.2025 07:05 — 👍 0 🔁 0 💬 0 📌 0
During May 2025 Clinical Knowledge Summaries were published or updated in the following areas. Appendicitis Corticosteroids - inhaled Cough Dupuytren's disease Menopause Neck lump Pityriasis versicolor Vitiligo All of the topics have been reviewed and... https://www.prescriber.org.uk/?p=1849
04.06.2025 07:04 — 👍 0 🔁 0 💬 0 📌 0
The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of May 2025. This month there is one guideline and one technology appraisal that impact upon primary care. The Suspected cancer: recognition... https://www.prescriber.org.uk/?p=1848
28.05.2025 07:49 — 👍 0 🔁 0 💬 0 📌 0
The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Drug Safety Update for May 2025. This update warns clinicians of an increased risk of intrahepatic cholestasis of pregnancy (ICP) associated with thiopurines (azathioprine,... https://www.prescriber.org.uk/?p=1847
20.05.2025 07:55 — 👍 0 🔁 0 💬 0 📌 0
During April 2025 Clinical Knowledge Summaries were published or updated in the following areas. Bronchiectasis Cataracts Chronic pain Itch in pregnancy Pityriasis rosea All of the topics have been reviewed and updated with minor structural and layout... https://www.prescriber.org.uk/?p=1846
06.05.2025 06:50 — 👍 0 🔁 0 💬 0 📌 0
The Department of Health and Social Care has announced that NHS prescription charges will be frozen for the first time in 3 years to help with the cost of living. Charges for prescriptions will remain at £9.90 for a single charge or £32.05 for a 3-month... https://www.prescriber.org.uk/?p=1845
01.05.2025 07:26 — 👍 1 🔁 0 💬 0 📌 0
The National Institute for Health and Care Excellence (NICE) have published new or updated guidance for the month of April 2025. This month there are two guidelines that impact upon primary care. The Suspected cancer: recognition and referral guideline has... https://www.prescriber.org.uk/?p=1844
29.04.2025 07:19 — 👍 0 🔁 0 💬 0 📌 0
The Medicines and Healthcare products Regulatory Agency (MHRA) has published a second Drug Safety Update for April 2025. This update reminds healthcare professionals and patients of the risk of severe asthma attacks and increased mortality associated with... https://www.prescriber.org.uk/?p=1843
25.04.2025 08:42 — 👍 0 🔁 0 💬 0 📌 0
The Medicines and Healthcare products Regulatory Agency (MHRA) has published a Drug Safety Update for April 2025. This update warns clinicians about the risk of liver injury with fezolinetant▼ (Veoza®). This is a relatively new treatment for moderate to... https://www.prescriber.org.uk/?p=1842
11.04.2025 07:05 — 👍 0 🔁 0 💬 0 📌 0
The Scottish Medicines Consortium (SMC) has issued its monthly advice on newly licensed medicines. Dapagliflozin (Forxiga®) has been accepted for restricted use in adults for the treatment of chronic kidney disease (CKD). The restriction limits use to... https://www.prescriber.org.uk/?p=1841
08.04.2025 07:28 — 👍 0 🔁 0 💬 0 📌 0
